New technologies in interventional cardiology further enhance the company’s comprehensive portfolio of cardiology solutions across the full c...
American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study r...
Personalized peripheral focused ultrasound therapy has potential as non-invasive, non-pharmacological alternative for chronic disease management Encoura...
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammatio...
Charles River Laboratories International, Inc. announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collec...
Helps support faster diagnosis, enabling earlier treatment of eye conditions Enables a more digitally connected primary care exam Facilitates collabora...
Fezolinetant is an investigational nonhormonal treatment for vasomotor symptoms (VMS) associated with menopause More than half of women ages 40 to 64 wor...
Royal Philips a global leader in health technology, announced the launch of Visual Patient Avatar, a revolutionary new monitoring solution that...
GE HealthCare (Nasdaq: GEHC) today announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA)&mdash...
SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic tech...
Danaher's new motto is "Accelerating the Power of Science and Technology to Improve Human Health." The organization's renewed focus is on driving innovatio...
A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fi...
SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic tech...
© 2024 Biopharma Boardroom. All Rights Reserved.
